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Abstract
Background: On the 30th September 2009, the pandemic (H1N1) 2009 influenza vaccine was made available to adults 
and children aged 10 years and over, in Australia. Acceptance of a novel vaccine is influenced by perceptions of risk 
including risk of infection, risk of death or severe illness and risk of serious vaccine side-effects. We surveyed a sample of 
residents from Sydney, Australia to ascertain their risk perception, attitudes towards the pandemic and willingness to 
accept the pandemic (H1N1) 2009 influenza vaccine.
Methods: We sampled residents using a cross-sectional intercept design during the WHO Phase 6. Members of the 
public were approached in shopping and pedestrian malls to undertake the survey during September and October 
2009. The survey measured perceived risk, seriousness of disease, recent behavioural changes, likely acceptance of the 
pandemic (H1N1) 2009 vaccine and issues relating to uptake and perceived safety.
Results: Of the 627 respondents, the majority felt that they had a "very low to low" (332/627, 52.9%) risk of acquiring 
H1N1. 24.5% (154/627) of respondents believed that the disease would "very seriously or extremely" affect their health. 
Nearly half (305/627, 48.6%) reported that in response to the "swine flu" outbreak they had undertaken one or more of 
the investigated behavioural changes. Overall, the self-reported likelihood of accepting vaccination against novel 
H1N1 was 54.7% (343/627).
Conclusions: While, most participants did not believe they were at high risk of acquiring pandemic H1N1 2009, over 
half of the sample indicated that they would accept the vaccine. Participants who were vaccinated against the 
seasonal influenza were more likely to receive the H1N1 vaccine. Concerns about safety, the possibility of side effects 
and the vaccine development process need to be addressed.
Background
In April 2009, the Mexican Secretariat of Health reported
an outbreak of respiratory disease. In the affected
patients, a novel swine origin influenza A (H1N1 09)
virus was detected [1,2]. Evidence that this new strain
could pass from human-to-human led the World Health
Organization (WHO) to quickly raise its pandemic alert
level to phase 5 on April 29th, representing "a strong sig-
nal that a pandemic is imminent and that the time to fina-
lise the organisation, communication and
implementation of the planned mitigation measures is
short" [3]. After documentation of human-to-human
transmission of the virus in at least three countries across
two WHO regions, the WHO raised the pandemic level
to 6 on June 11th [4].
Australia experienced the pandemic influenza A
(H1N1) 2009 outbreak at the same time that seasonal
influenza circulation was expected. Victoria was the first
Australian state to report a significant number of cases,
followed by New South Wales [5]. The first wave lasted
18 weeks in Australia from mid-May to late September
2009. The rate of hospitalisations was 23 per 100,000
population, with indigenous Australians overrepresented
[6]. The highest rate of hospitalisation occurred among
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c h i l d r e n  u n d e r  5  y e a r s  o f  a g e  [ 6 ] .  As  o f  F e b rua ry  1 9 th
2010, there have been 37,713 confirmed cases of pan-
demic (H1N1) 2009 in Australia, including 191 pandemic
influenza-associated deaths [7].
Since 17 June 2009, Australia's response to the pan-
demic has been guided by the PROTECT phase within
the Australian Health Management Plan for Pandemic
Influenza (AHMPPI) [8]. This newly developed phase
focused on identifying and treating infection in people
with moderate to severe disease and those with certain
risk factors (i.e. underlying chronic diseases), controlling
outbreaks in institutions and monitoring hospitalisations
[9]. On September 30th 2009, the pandemic (H1N1) 2009
vaccine was made available to adults and children aged 10
years and over, in Australia. The Australian Government
purchased 21 million doses of H1N1 vaccine [10]. On the
basis of local safety and immunogenicity trial results the
pandemic H1N1 09 influenza vaccine was registered by
the Australian Therapeutic Goods Administration [11].
To assess the associations between risk perceptions of
the pandemic (H1N1) 2009 influenza and intended pro-
tective behaviour changes, including willingness to be
vaccinated, we carried out a community survey in Syd-
ney, Australia. The aim of this study was to examine atti-
tudes, concerns and behaviours around pandemic
influenza (H1N1) 2009 in the general public.
Methods
Between September 5th and October 3rd 2009, we con-
ducted a cross-sectional intercept survey in Sydney Aus-
tralia to explore the community beliefs and risk
perceptions to the influenza A (H1N1) 2009 pandemic
and their attitude towards the vaccine.
Participants and sampling
Members of the public were approached in public shop-
ping and pedestrian malls and invited to participate in the
survey. Seven geographic areas in Sydney were selected
for recruitment based on socio-economically diverse
populations. Four of the authors (HS/AH/KW/CL) spent
two hours in each area recruiting participants at ran-
domly chosen times of the day. During a two-hour period
every fifth person was approached. The recruiter
approached adults 18 years of age or older and if the
recruiter was unable to determine age the participants
were asked. Participants were excluded if the researcher
experienced communication difficulties with them or
they were not residents of Sydney . Ethics approval was
obtained from the University of New South Wales, Syd-
ney, Australia.
Survey
Pandemic (H1N1) 2009 was referred to by its vernacular
alternative "swine flu" in the survey. Four items assessed
the participants perceived personal risk level and the risk
level they perceived for the general community, perceived
seriousness of the disease if it was contracted, and knowl-
edge of cases of H1N1 amongst family and friends. Items
measuring perception of risk and seriousness were
assessed on a five point Likert-type scale. On the same
scale, participants were asked to respond to the following
two statements: 'In general, I think the authorities are
doing a good job of dealing with the "swine flu" pandemic'
and 'I do not understand what is happening with this
"swine flu" pandemic'. The questions on perception of
risk had been pilot tested prior to inclusion in our first
community H1N1 study which was undertaken in Sydney
in April 2009 [12].
Participants were asked eight items about recent influ-
enza-related behaviours. Five items related to avoidance
of places, activities or behaviours. Three items related to
recommended pathogen avoidance activities; increased
cleaning or disinfecting of surfaces, washing hands with
soap and water more often than usual and using alcoholic
hand gel more than usual. All items measured recent
behaviour and were phrased "Over the past month, I have
... because of swine flu". The wording for this question
was adapted with permission from a survey undertaken
on influenza (H1N1) 2009 by Rubin et al [13].
Three items assessed awareness of the pandemic
(H1N1) 2009 influenza vaccination, and intention for
uptake while a further five items assessed the attitudes of
participants towards the vaccine on a five point Likert-
type scale. Sociodemographic variables included
responses to gender, age, highest educational qualifica-
tion, employment status, household composition, ethnic-
ity and uptake of an annual influenza vaccine in the
preceding influenza seasons (2007, 2008 and 2009). All
variables used tick boxes with the exception of one open-
ended question to determine reasons for acceptance or
refusal of the H1N1 09 influenza vaccine
Data analysis
The Pearson chi-square test was used to assess statistical
association in univariate analyses and a p-value of < 0.05
was considered significant. Calculation of crude odds
ratios (COR) and the chi-squared test were performed
using EpiInfo (version 3.3.2) CDC, Atlanta, GA. During
analysis, response categories were collapsed into agree,
disagree or unsure. Multivariate analysis using SPSS ver-
sion 17.0 (SPSS Inc. 2008) identified significant indepen-
dent predictors of acceptance of a pandemic (H1N1) 2009
vaccine, calculating adjusted odds ratios (AOR) after con-
trolling for gender, age, ethnicity, seasonal influenza vac-
cination in the 2008/2009 seasons, personal risk for
H1N1 influenza perceived as high to very high, perceived
affect on health as very to extremely affected, undertak-
ing more than one behavioural change due to H1N1 andSeale et al. BMC Infectious Diseases 2010, 10:99
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perception that the H1N1 situation is serious. Age, gen-
der and educational attainment were compared with the
Australian Bureau of Statistics 2006 census data for met-
ropolitan Sydney [14] to assess representativeness to the
Sydney population. Content analysis was performed on
all written responses to reasons for supporting/opposing
pandemic (H1N1) 2009 vaccination. Each statement was
coded into a category from a list of themes developed
from the data by four authors (HS, AH, KW and CL).
Results
A total of 1458 persons were approached and inclusion
criteria assessed, with 73 excluded as they were not resi-
dents of Sydney, 35 due to insufficient English proficiency
and another 10 as they were <18 years of age. Of the eligi-
ble persons, 627 (47.0%) agreed to participate. Compared
to Sydney residents [14], respondents were younger with
50% of survey respondents aged <35 years compared to
33% of Sydney residents and more likely to be university
educated (57%) compared to 43% of Sydney residents.
Demographic characteristics of the participants are listed
in Table 1.
Few (15.8%, 99/627) participants rated the average Syd-
ney resident's risk of acquiring H1N1 as "very high" to
"high" while the remainder rated the risk as "medium"
(39.4%, 247/627) or "very low to low" (43.4%, 272/627)
(Table 2). Rating of their own risk followed a similar pat-
tern with few (17.4%, 109/627) rating it at "very high" to
"high". Just under half (43.9%) of participants believed the
current H1N1 situation was serious. While, just over half
(52.0%, 326/627), believed they had no control over
whether they got "swine flu". Most (68.7%, 431/627) had
not witnessed their friends or family having "swine flu"
and many also (59.8%, 375/627) believed people were still
going to catch it six months time. If acquired, 61.4% of
participants rated pandemic (H1N1) 2009 influenza as
"somewhat affecting" their own health, while a quarter
(24.5%, 154/627) thought their health would be
"extremely" to "very seriously" affected. Of concern, 37.0%
(232/627) of respondents did not understand what was
happening with the "swine flu" pandemic.
Two or more changes to behaviour were reported in
response to the swine flu situation by just under half
(45.8%, 272/594) of the participants (Table 3). The most
common changes included hand cleansing through
increased hand washing (48.3%, 303/627) and the use of
alcoholic hand gel (37.6%, 236/627). People, who
reported that their risk level of acquiring "swine flu" was
"high" to "very high", were 2.8 times more likely (OR 2.8,
CI95 1.7-4.7, p < 0.0001) to modify their behaviours
because of "swine flu".
Over 50% (54.7%, 343/627) of the participants indicated
that they intended to be vaccinated against novel H1N1
influenza. We found no association between gender or
Table 1: Demographic characteristics of the participants
Characteristic % (No. of participants)
N = 627
Sex
Male 40.7% (255)
Female 57.1% (358)
Not specified 2.2% (14)
Age group (years)
18-24 23.9% (150)
25-34 26.0% (163)
35-44 16.3% (102)
45-54 13.9% (87)
55-64 12.1% (76)
≥ 65 5.3% (33)
Not specified 2.6% (16)
Home/living arrangements
Live Alone 16.1% (101)
Live in shared 
accommodation
14.7% (92)
Live with parents 16.7% (105)
Live with partner/
spouse
29.2% (183)
Live with partner/
spouse and children
17.5% (110)
Other 3.3% (21)
Not specified 2.4% (15)
Highest qualification
None 2.4% (15)
School certificate 5.9% (37)
High school certificate 16.4% (103)
College certificate/
diploma (Tafe)
16.3% (102)
University degree/
equivalent
56.9% (357)
Not specified 2.1% (13)
Ethnic Background
Caucasian 67.1% (421)
Other 30.3% (190)
Not specified 2.6% (16)
Employed
Working 79.3 (497)
Not working 18.2 (114)
Not specified 2.6 (16)
Received seasonal vaccine
2009 28.7% (180)
2008 and 2009 21.7% (136)Seale et al. BMC Infectious Diseases 2010, 10:99
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Table 2: Participant risk perceptions and attitudes towards pandemic influenza (H1N1) 2009
Question Response (N = 627)
% (n)
What level of risk do you think the average 
Sydney resident has of catching influenza 
A H1N1 or "swine flu" during this 
pandemic?
Very High - High 15.8% (99)
Medium 39.4% (247)
Very low - Low 43.4% (272)
Unsure/Not specified 1.4% (9)
What level of risk do you think you have of 
catching influenza A H1N1 or "swine flu" 
during this pandemic?
Very High - High 17.4% (109)
Medium 27.9% (175)
Very low - Low 52.9% (332)
Unsure/Not specified 1.8% (11)
If you were infected with "swine flu", how 
seriously do you think it would affect your 
health?
Not at all 7.3% (46)
Somewhat affect 61.4% (385)
Extremely-Very seriously affect 24.5% (154)
Unsure/Not specified 6.7% (42)
I think the current "swine flu" situation is 
serious
Agree 43.9% (275)
Disagree 37.3% (234)
Unsure/Not specified 18.7% (117)
I do not understand what is happening 
with this "swine Flu" pandemic
Agree 19.9% (125)
Disagree 63.0% (395)
Unsure/Not specified 17.1% (107)
In general, I think the authorities are doing 
a good job of dealing with the "swine flu" 
pandemic
Agree 57.7% (361)
Disagree 13.4% (84)
Unsure/Not specified 29.0% (182)
I think that whether I get the "swine flu" or 
not is out of my control
Agree 52.0% (326)
Disagree 33.3% (209)
Unsure/Not specified 14.6% (92)
In my opinion, people are still going to be 
catching "swine flu" six months from now
Agree 59.8% (375)
Disagree 10.4% (65)
Unsure/Not specified 29.9% (187)
Have there been cases of "swine flu" 
amongst your family or friends?
Yes 27.3% (171)
No 68.7% (431)
Unsure/Not specified 4.0% (25)Seale et al. BMC Infectious Diseases 2010, 10:99
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level of education and intention to receive the H1N1 vac-
cine. Participants from non-Caucasian ethnic groups
were significantly more likely (COR 1.6, CI95 1.1-2.3, p =
0.01) to report an intention to be vaccinated with the
novel H1N1 vaccine. Participants who believed they were
personally at risk (rating high to very high risk of acquir-
ing H1N1) were 1.9 times more likely (COR 1.9, CI95 1.2-
3.0, p = 0.005) to intend to be vaccinated. There was no
significant difference in vaccine acceptance between par-
ticipants who reported cases of H1N1 amongst their
friends or family members and those who did not (Table
4).
Participants who received the seasonal vaccine in 2008
or 2009 were 2.7 times more likely (COR 2.7, CI95 1.8-
4.0, p < 0.0001) to accept the novel H1N1 when compared
with participants who had not received an annual influ-
enza vaccine (Table 4). As expected, uptake of the 2009
seasonal influenza vaccine increased significantly with
age, with vaccine uptake ranging from 20.6% (31/150) for
the 18-24 age group to 60.6% (20/33) for those partici-
pants 65 years and older (p < 0.001). In comparison, par-
ticipants aged 18-24 years were 1.8 times more likely
(COR 1.8, CI95 1.2-2.6, p = 0.003) to indicate an intention
to receive the pandemic H1N1 2009 influenza vaccine
compared to older age groups. This did not remain signif-
icant on multivariate analysis (Table 4). The study partici-
pants were asked if they were concerned about vaccine
safety, of which 266/627 (42%) reported that they were. A
similar proportion stated that they were concerned that
the vaccine had not been tested adequately (258/627,
41%). Whilst 252/627 (40%) respondents believed that the
vaccine may cause people to get influenza (Table 5).
Responses were received from 491/627 participants
regarding why they would or would not accept the pan-
demic H1N1 2009 influenza vaccine. Close to half (49.9%,
245/491) of the responses were classified as being in sup-
port of the novel H1N1 vaccine. A common supportive
reason was the belief that the vaccine would provide self
protection (32.6%, 80/245), followed by the belief that the
novel vaccine would provide general protection to the
community and would halt the spread of the disease
(31%, 76/245). Some participants classified themselves at
high risk of influenza and therefore believed it was
extremely important to be vaccinated, whereas others
expressed an obligation to be vaccinated because of work
commitments. A general belief or confidence in vaccina-
tion was commonly expressed as a reason for accepting
the vaccine. Some participants believed that the novel
H1N1 2009 influenza vaccine was the same as the "nor-
mal influenza vaccine" and therefore intended to be vac-
cinated as they would normally do against seasonal
influenza.
The main reasons given for not accepting the new vac-
cine included the belief that the pandemic H1N1 2009
influenza situation was not serious enough to warrant
vaccination (29.3%, 72/246,) or they did not perceive
themselves to be at-risk (17.1%, 42/246) (Figure 1). Many
people believed that H1N1 was just "another" influenza
strain or it was just the "normal" flu. For some partici-
pants who expressed concerns, the focus related to the
clinical trials conducted or the safety of the vaccine and
the side-effects. Comments included a belief that vacci-
nation for the novel H1N1 influenza strain was unneces-
sary because they were young and/or healthy and they
believed that their immune system could deal with the
virus. One male participant aged 55-64 years stated "I see
no reason to treat swine flu any more seriously than flu.
Maintaining a healthy lifestyle is much more important".
Discussion
On the 18th of September 2009, Australia's independent
medicines' regulator, the Therapeutic Goods Administra-
tion (TGA), announced it was to register the CSL Bio-
therapies pandemic (H1N1) 2009 influenza vaccine.
Human adult trials had indicated that the pandemic vac-
cine was similar to that of the seasonal influenza vaccine
with a high safety and low adverse events profile [11,15].
Table 3: Behavioural responses to pandemic influenza 
(H1N1) 2009
"Over the past month, I 
have ... because of swine 
flu":
% (n) of positive responses
Washed my hands with soap 
and water more often than 
usual
48.3 (303)
Used alcoholic hand gel 
more than usual
37.6 (236)
Increased the amount I clean 
or disinfect things that I 
might touch, such as door 
knobs
31.1 (195)
Kept away from crowded 
places generally
8.6 (54)
Reduced the amount I use 
public transport
7.3 (46)
Deliberately cancelled or 
postponed a social event, 
such as meeting friends, 
eating out, or going to a 
sports event
6.2 (39)
Reduced the amount I go 
into shops
4.9 (31)
Kept one or more of my 
children out of school or pre-
school
3.3 (21)Seale et al. BMC Infectious Diseases 2010, 10:99
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The registration announcement marked the commence-
ment of the vaccination program for Australian adults.
However, it also came at a time when many countries in
the temperate regions of the southern hemisphere (Chile,
Argentina, Australia, and New Zealand) had passed the
peak of their winter influenza epidemic.
We found that less than 20% of our sample perceived
that they were at significantly high risk of acquiring
H1N1. This finding is comparable to the results reported
in our earlier survey, which was conducted in Sydney
during the WHO Pandemic Phase Five [12]. Our results
are also echoed in other H1N1 studies conducted in Aus-
tralia and overseas. For example, Lau et al found that only
10% of their participants (Hong Kong general public)
considered themselves (10%, n = 31), their family mem-
bers (10%, n = 30), or the general public (12%, n = 35) to
have a high or very high chance of contracting A/H1N1 in
the next year [16]. Eastwood et al, reported a slightly
higher proportion (25%) of their cohort (Australian resi-
dents) perceived themselves to be at increased risk of
infection [17]. It is perhaps not surprising that there is a
low perception of risk amongst the community, as many
of the reports on H1N1 in the newspapers and other
media channels documented the virus as only causing
mild influenza.
The acceptance of, and adherence to public health mea-
sures by the population depends largely on the way peo-
ple perceive a threat. Pre-pandemic surveys and post-
SARS studies have illustrated a dose-response relation-
ship between the severity of pandemic and public
response [18,19]. Given the reported mildness of the
H1N1 2009 pandemic and overall low anxiety expressed
by our surveyed participant's, low rates of behaviour
change could have been expected. Surprisingly however,
over half of our participants changed at least one, and
commonly two, behaviours in response to the situation.
This is in stark contrast with the findings of Rubin et al
[13], who reported that in the early stages of the pan-
demic, only forty nine people (4.9%) engaged in one or
more of the avoidance behaviours, and 377 (37.8%) said
that they had carried out one or more of the three recom-
mended behaviours. Whilst our participants did not
Table 4: Reported willingness of survey participants to accept a pandemic (H1N1) 2009 influenza vaccine
Variable Stated acceptance of pandemic (H1N1) 2009 vaccine
Yes
(N = 343)
% (n)
No/will wait N = 269
% (n)
Univariate analysis
COR (CI95) [p value]
Multivariate analysis
AOR (CI95) [p value]
Gender
Men 40.8% (140) 39.1% (111) 1 -
Women 58.3% (200) 52.8% (150) 0.9 (0.7-1.3) [0.7]
Not specified 0.9% (3) 2.8% (8) -
Age group
18-34 53.6% (184) 43.7% (124) 1.4 (0.9-2.1) [0.2] -
35-54 29.2% (100) 29.6% (84) 1.1 (0.7-1.7) [0.7]
55+ 16.3% (56) 18.0% (51) 1 [0.3]
Not specified 0.9% (3) 3.5% (10) -
Ethnicity (Other) 35.6% (122) 23.6% (67) 1.7 (1.1-2.4) [0.01] 1.6 (1.0-2.4) [0.03] *
Received seasonal 
influenza vaccine in 
08/09
37.6% (129) 16.9% (48) 2.7 (1.8-4.2) [<0.001] 2.7 (1.7-3.6) [<0.001]*
Personal risk† 21.3% (73) 12.0% (34) 1.9 (1.2-3.0) [0.005] -
Undertake ≥ 1 
behavioural change 
due to H1N1 situation
60.6% (208) 41.2% (117) 2.0 (1.4-2.8) [<0.001] 1.8 (1.2-2.5) [0.003]*
Perceives H1N1 
situation as serious
55.7% (191) 27.5% (78) 3.1 (2.2-4.4) [<0.001] 2.5 (1.7-3.6) [<0.001]*
COR = Crude odds ratio; AOR = Adjusted odds ratio
†"High to very high",
* Adjusted for other variables in the model (gender, age, ethnicity, received vaccination for 2008/2009 seasons, risk for H1N1 flu perceived as 
high to very high, perceived affect on health as very to extremely affected,
undertaken more than one behaviour change due to H1N1 and perception that H1N1 situation is seriousSeale et al. BMC Infectious Diseases 2010, 10:99
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believe that they were at high risk of acquiring the dis-
ease, the concerns about the consequences if caught may
have been sufficient enabler to adopt relatively simple
changes in behaviour.
Given that pandemic H1N1 2009 influenza was gener-
a l l y  m i l d  i n  t h o s e  w i t h o u t  r i s k  f a c t o r s ,  t h e  A u s t r a l i a n
Government revised its pandemic plan to include the
PROTECT phase, focusing on managing local outbreaks
especially in vulnerable groups in whom disease may be
serious [20]. As part of this revised plan certain measures
employed at earlier stages of the national response were
adjusted to ensure they supported the current situation.
Although this phase continued to promote individual
protection measures, such as personal hygiene, cough eti-
quette and voluntary isolation if symptomatic, it did not
recommend the general avoidance of public places or
activities. It was not surprising that few of our partici-
pants reported to keep away from public places and pub-
lic transportation.
People most vulnerable to pandemic H1N1 2009 influ-
enza infection, such as those with chronic respiratory dis-
ease, diabetes, cancer, severe obesity and conditions that
suppress the immune system, as well as pregnant women
and Indigenous Australians were encouraged to be the
first recipients of the H1N1 vaccine. However, the vac-
cine was also made freely available to all Australians,
through their local primary health care provider or
immunisation provider. In comparison, in Australian the
annual influenza vaccine is only provided free to Indige-
nous people aged over 50, or aged 15 to 49 who are at
high risk (according to NHMRC recommendations), and
all adults aged 65 years and older under the National
Immunisation Program [21]. National provisional data
collected in November and December 2009 by the Aus-
tralian Institute of Health and Welfare showed that
among the adult age groups (ages 18 to 64 years), there
had only been a 14% uptake of the pandemic H1N1 2009
influenza vaccine [22]. In comparison, receipt of the vac-
cine was three times higher in those aged 65 years and
over (42%) [22].
Given that many of our participants believed that the
pandemic situation was over, it was pleasing to find that
54% of those surveyed in our study indicated a willing-
ness to receive pandemic H1N1 2009 influenza vaccine.
International studies assessing willingness to receive the
pandemic H1N1 2009 influenza vaccine have reported
rates that range from 36.9% (Greece [23]) to 49.6%
(United States [24]). Our findings also suggest that beliefs
about seasonal influenza vaccination will influence
uptake of novel H1N1 vaccine. For example, we deter-
mined that (1) annual influenza recipients were signifi-
cantly more likely to accept the pandemic H1N1 2009
influenza vaccine compared to their unvaccinated coun-
terparts and (2) many participants likened the H1N1
Table 5: Participant attitudes towards the pandemic 
(H1N1) 2009 influenza vaccine
Vaccination statements Participant responses
% (n)
If a "swine flu" vaccine was 
made available to the 
general
public, would you get 
vaccinated?
Yes 54.7% (343)
No 42.9% (269)
Not specified 2.3% (15)
Only people who are have 
underlying medical 
problems or who are 
pregnant should be 
vaccinated
Agree 34.9% (219)
Disagree 46.3% (290)
Unsure 16.6% (104)
Not specified 2.2% (14)
I will get the "swine flu" 
vaccine if the Australian 
government recommends 
it
Agree 52.5% (329)
Disagree 25.4% (159)
Unsure 19.8% (124)
Not specified 2.4% (15)
I will get the "swine flu" 
vaccine if my doctor 
recommends it
Agree 71.5% (448)
Disagree 13.4% (84)
Unsure 12.8% (81)
Not specified 2.2% (14)
The "swine flu" vaccine will 
protect me from the "swine 
flu"
Agree 44.7% (280)
Disagree 14.7% (92)
Unsure 37.8% (237)
Not specified 2.9% (18)
I am concerned about the 
side effects of the "swine 
flu" vaccine
Agree 42.4% (266)
Disagree 27.6% (173)
Unsure 27.3% (171)Seale et al. BMC Infectious Diseases 2010, 10:99
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influenza strain to being a "normal" strain of influenza,
which was no more "serious" or "dangerous".
While 45% of our participants believed that the H1N1
vaccine would protect them against acquiring "swine flu",
a similar proportion were concerned about the safety of
the vaccine and the possibility of side effects. Common
fears expressed, were that: (1) the vaccine had been
"rushed through"; (2) there had been "insufficient
research"; (3) the vaccine had not been "tested ade-
q u a t e l y "  a n d  ( 4 )  " l o n g  t e r m  s t u d i e s "  w e r e  r e q u i r e d  t o
ensure its "safety". This suggests that many of our partici-
pants have a lack of understanding about the process of
developing seasonal influenza vaccine based on the prob-
ability of strains. While we only looked at a small subset
of the population in Sydney, if these results were found to
be representative, educational materials distributed about
the pandemic influenza vaccine should focus on its safety
record, manufacturing and the similarities between sea-
sonal influenza vaccination and pandemic vaccine to help
dispel these fears. Vaccine uptake may also be increased if
General Practitioners actively promote the pandemic
vaccine to their patients, given the fact that we found
higher rates of compliance for physician recommended
vaccination, than for government recommendation.
This study has several limitations. Firstly, we only
recruited from one city of Australia. We therefore recog-
nise the limitations of applying the results of this study to
the broader Australian population. Secondly, people who
could not communicate in English were excluded from
the sample, which may have affected representation of
ethnic minorities. Additional research is required to
examine the differing reactions to the outbreak among
these groups. Thirdly, as participation in our study was
on a voluntary basis, this study has potential for self-
selection bias by community members who are particu-
larly concerned about pandemic influenza. Fourthly, this
survey measured the samples views at a specific point in
time, therefore the beliefs and attitudes reflect the infor-
mation available at that time. We also did not elaborate
on "requests by authorities," possibly causing participants
to confuse mandatory behaviours with behaviours
strongly recommended by public health authorities.
Not specified 2.7% (17)
I am concerned that the 
vaccine has not been tested 
adequately
Agree 41.1% (258)
Disagree 24.4% (153)
Unsure 32.2% (202)
Not specified 2.2% (14)
The "swine flu" vaccine may 
cause the "flu" in some 
people
Agree 40.2% (252)
Disagree 17.9% (112)
Unsure 39.6% (248)
Not specified 2.2% (15)
The "swine flu" vaccine will 
stop the spread of "swine 
flu"
Agree 30.9% (194)
Disagree 24.6% (154)
Unsure 42.1% (264)
Not specified 2.4% (15)
Table 5: Participant attitudes towards the pandemic 
(H1N1) 2009 influenza vaccine (Continued)
Figure 1 Primary reason stated by participants for not accepting the pandemic (H1N1) 2009 influenza vaccine (N = 246).Seale et al. BMC Infectious Diseases 2010, 10:99
http://www.biomedcentral.com/1471-2334/10/99
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Conclusions
W h i l e ,  m o s t  p a r t i c i p a n t s  d i d  n o t  b e l i e v e  t h e y  w e r e  a t
high risk of acquiring pandemic H1N1 2009 influenza,
over half of the sample indicated that they would accept
the vaccine. Participants who were vaccinated against the
seasonal influenza were more likely to intend to receive
the pandemic H1N1 2009 influenza vaccine. Concerns
about safety, the possibility of side effects and the vaccine
development process need to be addressed.
Competing interests
Raina MacIntyre receives funding from influenza vaccine manufacturers GSK
and CSL Biotherapies for investigator-driven research. Kirsten Ward has
received funding from vaccine manufacturer Wyeth to attend a conference.
Neither of these payments was associated with this study. The remaining
authors have no competing interests.
Authors' contributions
HS participated in the design of the study and survey, undertook the distribu-
tion and collection, performed the analysis and drafted the manuscript. AH/
MLM participated in the design of the study and survey, assisted with the anal-
ysis and reviewed the manuscript. KW/CL/DV helped perform the statistical
analysis and drafted the manuscript. CRM participated in its design and coordi-
nation and helped to draft the manuscript. All authors read and approved the
final manuscript.
Author Details
1School of Public Health and Community Medicine, Faculty of Medicine, The 
University of New South Wales, Sydney, Australia, 2General Practice, NSW, 
Sydney, Australia, 3Public Health Nurse, Sydney, Australia, 4Medical Student, 
Faculty of Medicine, The University of New South Wales, Sydney, Australia and 
5National Centre for Immunisation Research and Surveillance of Vaccine 
Preventable Diseases (NCIRS), The Children's Hospital at Westmead and 
Discipline of Paediatrics and Child Health, University of Sydney, Sydney, 
Australia
References
1. Swine influenza A (H1N1) infection in two children - Southern 
California.  MMWR Morb Mortal Wkly 2009, 58:400-402.
2. Update: infections with a swine-origin influenza A (H1N1) virus - 
United States and other countries.  MMWR Morb Mortal Wkly Rep 2009, 
58:431-433.
3. Current WHO phase of pandemic alert   [http://www.who.int/csr/
disease/avian_influenza/phase/en/index.html]
4. Influenza A (H1N1) - update 14   [http://www.who.int/csr/don/
2009_05_04a/en/index.html]
5. Sentinel influenza surveillance   [http://www.vidrl.org.au/surveillance/
flu%20reports/flurpt09/flu09.html]
6. Bishop JF, Murnane MP, Owen R: Australia's winter with the 2009 
Pandemic Influenza A (H1N1) Virus.  N Engl J Med 2009, 361:2591-2594.
7. Australian Influenza Surveillance report No 7   [http://
www.health.gov.au/internet/healthemergency/publishing.nsf/Content/
ozflu2010.htm/$File/ozflu-no7-2010.pdf]
8. New pandemic phase PROTECT   [http://www.health.gov.au/internet/
healthemergency/publishing.nsf/Content/news-170609]
9. Australia's response and data   [http://www.health.gov.au/internet/
healthemergency/publishing.nsf/Content/resources]
10. Pandemic (H1N1) 2009 Vaccine: Q&A's on pandemic vaccine   [http://
www.health.gov.au/internet/healthemergency/publishing.nsf/Content/
pandemic-vaccine-qna#2]
11. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, 
Dawson G, Hu W, Leggio C, Washington D, et al.: Response to a 
Monovalent 2009 Influenza A (H1N1) Vaccine.  N Engl J Med 2009, 
361:2405-2413.
12. Seale H, McLaws M, Heywood A, Ward K, Lowbridge C, Van D, Gralton J, 
MacIntyre CR: The community's attitude towards swine flu and 
pandemic influenza.  MJA 2009, 191:267-269.
13. Rubin GJ, Amlot R, Page L, Wessely S: Public perceptions, anxiety, and 
behaviour change in relation to the swine flu outbreak: cross sectional 
telephone survey.  BMJ 2009, 339:b2651.
14. Australian Bureau of Statistics: 2006 Census of Population and Housing. 
Sydney (Statistical Division) - NSW Age (Full classification list) by sex.  
vol. Cat. No. 2068 - 2006 Census Tables 2009.
15. Zhu F-C, Wang H, Fang H-H, Yang JG, Lin XJ, Liang X-F, Zhang X-F, Pan H-X, 
Meng F-Y, Hu YM, et al.: A Novel Influenza A (H1N1) Vaccine in Various 
Age Groups.  N Engl J Med 2009, 361:2414-2423.
16. Lau JT, Yeung NC, Choi KC, Cheng MY, Tsui HY, Griffiths S, Lau JTF, Yeung 
NCY, Cheng MYM, Griffiths S: Acceptability of A/H1N1 vaccination 
during pandemic phase of influenza A/H1N1 in Hong Kong: 
population based cross sectional survey.  BMJ 2009, 339:b4164.
17. Eastwood K, Durrheim D, Jones A, Butler M: Acceptance of pandemic 
(H1N1) 2009 influenza vaccination by the Australian public.  MJA 2009, 
192:33-36.
18. Smith BW, Kay VS, Hoyt TV, Bernard ML, Smith BW, Kay VS, Hoyt TV, 
Bernard ML: Predicting the anticipated emotional and behavioral 
responses to an avian flu outbreak.  Am J Infect Control 2009, 37:371-380.
19. Leung GM, Ho L-M, Chan SKK, Ho S-Y, Bacon-Shone J, Choy RYL, Hedley 
AJ, Lam T-H, Fielding R: Longitudinal assessment of community 
psychobehavioral responses during and after the 2003 outbreak of 
severe acute respiratory syndrome in Hong Kong.  Clin Infect Dis 2005, 
40:1713-1720.
20. Health Emergency - Update Bulletins for H1N1 09 2009   [http://
www.healthemergency.gov.au/internet/healthemergency/
publishing.nsf]
21. Influenza   [http://www.immunise.health.gov.au/internet/immunise/
publishing.nsf/Content/immunise-influenza]
22. Australian Institute of Health and Welfare: 2009 Adult Vaccination Survey 
Provisional topline results for H1N1 vaccination uptake.  Canberra: 
Australian Government Department of Health and Ageing; 2010. 
23. Sypsa V, Livanios T, Psichogiou M, Malliori M: Public perceptions in 
relation to intention to receive pandemic influenza vaccination in a 
random population sample: evidence from a cross-sectional telephone 
survey.  European Communicable Disease Bulletin 2009, 14:19437.
24. Maurer J, Harris KM, Parker A, Lurie N, Maurer J, Harris KM, Parker A, Lurie N: 
Does receipt of seasonal influenza vaccine predict intention to receive 
novel H1N1 vaccine: evidence from a nationally representative survey 
of U.S. adults.  Vaccine 2009, 27:5732-5734.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/10/99/prepub
doi: 10.1186/1471-2334-10-99
Cite this article as: Seale et al., Why do I need it? I am not at risk! Public per-
ceptions towards the pandemic (H1N1) 2009 vaccine BMC Infectious Diseases 
2010, 10:99
Received: 25 November 2009 Accepted: 19 April 2010 
Published: 19 April 2010
This article is available from: http://www.biomedcentral.com/1471-2334/10/99 © 2010 Seale et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Infectious Diseases 2010, 10:99